Clinical trial Recruiting at 1 site Interventional Ages 4 to 10

Nutritional supplements for muscle growth in children with spastic cerebral palsy

Official title: Feasibility Study: Nutritional Supplements to Support Muscle Growth in Children With Cerebral Palsy

Run by Universitaire Ziekenhuizen KU Leuven · NCT06044168 · Data updated 2026-11-12

This study is trying out a 10-week nutritional supplement plan with leucine to see if it helps children with spastic cerebral palsy grow stronger muscles.

More Spastic Cerebral Palsy trials

Quick facts

Study typeInterventional
Ages4 Years to 10 Years
SexAll
Enrollment5 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven, Vlaams-Brabant)
StatusRecruiting
StartedJuly 31, 2023
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedMay 5, 2026
Trial IDNCT06044168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children diagnosed with spastic cerebral palsy who have specific muscle volume criteria and are classified as level II or III on the Gross Motor Function Classification System.

Probably not a fit

Patients with dyskinesia, severe co-morbidities, or those who have undergone certain treatments or surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the feasibility of a 10-week nutritional supplement plan using leucine to enhance muscle growth in children diagnosed with spastic cerebral palsy. The research focuses on assessing the effects of leucine on macroscopic muscle morphology, including muscle volume and cross-sectional area. By utilizing 3D freehand ultrasound, the study aims to provide pilot analyses on how leucine supplementation may improve muscle properties in this population. The findings could pave the way for future interventions aimed at improving muscle strength and function in children with cerebral palsy.

Why it matters

Potential benefit: If successful, this study could lead to improved muscle strength and growth in children with spastic cerebral palsy, enhancing their physical capabilities.

How similar studies have gone: While nutritional supplementation has been explored in various contexts, this specific approach focusing on leucine in children with cerebral palsy is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Spastic Cerebral Palsy (diagnosed by a neuro-pediatrician from the CP Reference Centre of the University Hospital Leuven)

* Uni- of bilateral involvement
* Level II or III on the Gross Motor Function Classification System (GMFCS)
* Muscle volume for the medial gastrocnemius (target muscle) of at least 20% compared to the expected muscle volume in age-matched typically developing children

Exclusion Criteria:

* Presence of dyskinesia or ataxia
* Severe co-morbidities
* Botulinum toxin treatment ten months prior to assessment
* Previous orthopedic or neurosurgery
* Severe ankle deformities preventing fitting in test positions
* Ankle range of motion (ROM) \<30% of normal values

Where it's running

  • UZ Leuven
    Leuven, Vlaams-Brabant, Belgium
    Recruiting

Study contacts

  • Principal investigator: Kaat Desloovere, Prof. dr. — Department of Rehabilitation Sciences, KU Leuven, Belgium
  • Study coordinator: Ineke Verreydt
  • Email: ineke.verreydt@kuleuven.be
  • Phone: +3216341016

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.